Vitamin D and immune function: Autocrine, paracrine or endocrine?

References

• Moller KI, Kongshoj B, Philipsen PA, Thomsen VO, Wulf HC. How Finsen's light cured lupus vulgaris. Photodermatol Photoimmunol Photomed 2005;21:118–124.
   PubMed Web of Science ®Google Scholar
• Grad R. Cod and the consumptive: a brief history of cod-liver oil in the treatment of pulmonary tuberculosis. Pharmacy in history 2004;46:106–120.
   PubMedGoogle Scholar
• Herrera G. Vitamin D in massive doses as an adjuvant to the sulfones in the treatment of tuberculoid leprosy. Int J Lepr 1949;17:35–42.
   PubMedGoogle Scholar
• Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, . Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000;355:618–621.
   PubMed Web of Science ®Google Scholar
• Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN. Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infect 2005;50:432–437.
   PubMed Web of Science ®Google Scholar
• Williams B, Williams AJ, Anderson ST. Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr Infect Dis J 2008;27:941–942.
   PubMed Web of Science ®Google Scholar
• Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, Lisse IM, . Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009;179: 843–850.
   PubMed Web of Science ®Google Scholar
• Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, Hall BM, . A single dose of vitamin d enhances immunity to mycobacteria. Am J Respir Crit Care Med 2007;176:208–213.
   PubMed Web of Science ®Google Scholar
• Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones 2006;38:3–5.
   PubMedGoogle Scholar
• Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, . High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011;377:242–250.
   PubMed Web of Science ®Google Scholar
• Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR, . Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009;7:28.
   PubMed Web of Science ®Google Scholar
• Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA, Jr., Koeffler HP, . Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin Infect Dis 2009;48:418–424.
   PubMed Web of Science ®Google Scholar
• Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, . Epidemic influenza and vitamin D. Epidemiol Infect 2006;134:1129–1140.
   PubMed Web of Science ®Google Scholar
• Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S–1086S.
   PubMed Web of Science ®Google Scholar
• Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008;4:404–412.
   PubMedGoogle Scholar
• Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005;48:1247–1257.
   PubMed Web of Science ®Google Scholar
• Littorin B, Blom P, Scholin A, Arnqvist HJ, Blohme G, Bolinder J, . Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006;49:2847–2852.
   PubMed Web of Science ®Google Scholar
• Harris SS. Vitamin D in type 1 diabetes prevention. J Nutr 2005;135:323–325.
   PubMed Web of Science ®Google Scholar
• Ramos-Lopez E, Jansen T, Ivaskevicius V, Kahles H, Klepzig C, Oldenburg J, . Protection from type 1 diabetes by vitamin D receptor haplotypes. Ann N Y Acad Sci 2006;1079:327–334.
   PubMed Web of Science ®Google Scholar
• Bailey R, Cooper JD, Zeitels L, Smyth DJ, Yang JH, Walker NM, . Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 2007.
   Google Scholar
• Raghuwanshi A, Joshi SS, Christakos S. Vitamin D and multiple sclerosis. J Cell Biochem 2008;105:338–343.
   PubMed Web of Science ®Google Scholar
• Vagianos K, Bector S, McConnell J, Bernstein CN. Nutrition assessment of patients with inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2007;31:311–319.
   PubMed Web of Science ®Google Scholar
• Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih MC, . Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006;118:1950–1961.
   PubMed Web of Science ®Google Scholar
• Pappa HM, Grand RJ, Gordon CM. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis 2006;12:1162–1174.
   PubMed Web of Science ®Google Scholar
• Packey CD, Sartor RB. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 2009;22:292–301.
   PubMed Web of Science ®Google Scholar
• Rook GA, Steele J, Fraher L, Barker S, Karmali R, O'Riordan J, . Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986;57:159–163.
   PubMed Web of Science ®Google Scholar
• Adams JS, Gacad MA. Characterization of 1 alpha-hydroxylation of vitamin D3 sterols by cultured alveolar macrophages from patients with sarcoidosis. J Exp Med 1985;161:755–765.
   PubMed Web of Science ®Google Scholar
• Papapoulos SE, Clemens TL, Fraher LJ, Lewin IG, Sandler LM, O'Riordan JL. 1, 25-dihydroxycholecalciferol in the pathogenesis of the hypercalcaemia of sarcoidosis. Lancet 1979;1:627–630.
   PubMed Web of Science ®Google Scholar
• Hewison M, Burke F, Evans KN, Lammas DA, Sansom DM, Liu P, . Extra-renal 25-hydroxyvitamin D3 - 1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 2007;103:316–321.
   PubMed Web of Science ®Google Scholar
• Koeffler HP, Reichel H, Bishop JE, Norman AW. Gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun 1985;127:596–603.
   PubMed Web of Science ®Google Scholar
• Reichel H, Koeffler HP, Bishop JE, Norman AW. 25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J Clin Endocrinol Metab 1987;64:1–9.
   PubMed Web of Science ®Google Scholar
• Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, . Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001;86:888–894.
   PubMed Web of Science ®Google Scholar
• Fu GK, Lin D, Zhang MY, Bikle DD, Shackleton CH, Miller WL, . Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol 1997;11: 1961–1970.
   PubMed Web of Science ®Google Scholar
• Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, . Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770–1773.
   PubMed Web of Science ®Google Scholar
• Zaiou M, Gallo RL. Cathelicidins, essential gene-encoded mammalian antibiotics. J Mol Med 2002;80:549–561.
   PubMed Web of Science ®Google Scholar
• Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004;75:39–48.
   PubMed Web of Science ®Google Scholar
• Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, . Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004;173:2909–2912.
   PubMed Web of Science ®Google Scholar
• Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. Faseb J 2005;19:1067–1077.
   PubMed Web of Science ®Google Scholar
• Gombart AF, Saito T, Koeffler HP. Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics 2009;10:321.
   PubMed Web of Science ®Google Scholar
• Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, . Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009;182: 4289–4295.
   PubMed Web of Science ®Google Scholar
• Stoffels K, Overbergh L, Giulietti A, Verlinden L, Bouillon R, Mathieu C. Immune regulation of 25-hydroxyvitamin-D3 - 1alpha-hydroxylase in human monocytes. J Bone Miner Res 2006;21:37–47.
   PubMed Web of Science ®Google Scholar
• Krutzik SR, Hewison M, Liu PT, Robles JA, Stenger S, Adams JS, . IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 2008;181:7115–7120.
   PubMed Web of Science ®Google Scholar
• Liu PT, Schenk M, Walker VP, Dempsey PW, Kanchanapoomi M, Wheelwright M, . Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 2009;4:e5810.
   PubMed Web of Science ®Google Scholar
• Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, Tavera-Mendoza LE, . Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem 285:2227–2231.
   Google Scholar
• Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000;290:1717–1721.
   PubMed Web of Science ®Google Scholar
• Levine B, Deretic V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 2007;7: 767–777.
   PubMed Web of Science ®Google Scholar
• Yuk JM, Shin DM, Lee HM, Yang CS, Jin HS, Kim KK, . Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009;6:231–243.
   PubMed Web of Science ®Google Scholar
• Shin DM, Yuk JM, Lee HM, Lee SH, Son JW, Harding CV, . Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signalling. Cell Microbiol 2011;12:1648–1665.
   Google Scholar
• Lisse TS, Liu T, Irmler M, Beckers J, Chen H, Adams JS, . Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling. Faseb J 2011;25:937–947.
   PubMed Web of Science ®Google Scholar
• Fabri M, Realegeno SE, Jo EK, Modlin RL. Role of autophagy in the host response to microbial infection and potential for therapy. Curr Opin Immunol 2011;23:65–70.
   PubMed Web of Science ®Google Scholar
• Lisse TS, Hewison M. Vitamin D: a new player in the world of mTOR signaling. Cell Cycle 2011;10:1888–1889.
   PubMed Web of Science ®Google Scholar
• Edfeldt K, Liu PT, Chun R, Fabri M, Schenk M, Wheelwright M, . T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci U S A 2010;107:22593–22598.
   PubMed Web of Science ®Google Scholar
• Fabri M, Stenger S, Shin DM, Yuk JM, Liu PT, Realegeno S, . Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages. Sci Transl Med 2011;3:104ra102.
   PubMed Web of Science ®Google Scholar
• Sakaki T, Kagawa N, Yamamoto K, Inouye K. Metabolism of vitamin D3 by cytochromes P450. Front Biosci 2005;10:119–134.
   PubMed Web of Science ®Google Scholar
• Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3). J Cyst Fibros 2007;6:403–410.
   PubMed Web of Science ®Google Scholar
• Evans KN, Nguyen L, Chan J, Innes BA, Bulmer JN, Kilby MD, . Effects of 25-hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 on cytokine production by human decidual cells. Biol Reprod 2006;75:816–822.
   PubMed Web of Science ®Google Scholar
• Liu N, Kaplan AT, Low J, Nguyen L, Liu GY, Equils O, . Vitamin D Induces Innate Antibacterial Responses in Human Trophoblasts via an Intracrine Pathway. Biol Reprod 2009;80:398–406.
   PubMed Web of Science ®Google Scholar
• Schauber J, Dorschner RA, Yamasaki K, Brouha B, Gallo RL. Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli. Immunology 2006;118:509–519.
   PubMed Web of Science ®Google Scholar
• Schauber J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Kiken D, . Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 2007;117:803–811.
   PubMed Web of Science ®Google Scholar
• Montoya D, Cruz D, Teles RM, Lee DJ, Ochoa MT, Krutzik SR, . Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe 2009;6:343–353.
   PubMed Web of Science ®Google Scholar
• Yamamura M, Uyemura K, Deans RJ, Weinberg K, Rea TH, Bloom BR, . Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991;254:277–279.
   PubMed Web of Science ®Google Scholar
• Jullien D, Sieling PA, Uyemura K, Mar ND, Rea TH, Modlin RL. IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol 1997;158:800–806.
   PubMed Web of Science ®Google Scholar
• Liu PT, Wheelwright M, Teles R, Komisopoulou E, Edfeldt K, Ferguson B, . MicroRNA-21 targets the vitamin D-dependent antimicrobial pathway in leprosy. Nat Med 2012;18:267–273.
   PubMed Web of Science ®Google Scholar
• Agostini C, Semenzato G. Cytokines in sarcoidosis. Semin Respir Infect 1998;13:184–196.
   PubMedGoogle Scholar
• Kallas M, Green F, Hewison M, White C, Kline G. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab 2010;95: 3111–3117.
   PubMed Web of Science ®Google Scholar
• Brennan A, Katz DR, Nunn JD, Barker S, Hewison M, Fraher LJ, . Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol. Immunology 1987;61:457–461.
   PubMed Web of Science ®Google Scholar
• Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000;164:2405–2411.
   PubMed Web of Science ®Google Scholar
• Adorini L, Penna G, Giarratana N, Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem 2003;88:227–233.
   PubMed Web of Science ®Google Scholar
• Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S, . 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 2007;178: 145–153.
   PubMed Web of Science ®Google Scholar
• Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, . Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003;170:5382–5390.
   PubMed Web of Science ®Google Scholar
• Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M. Regulation of 25-hydroxyvitamin D3 - 1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood 2003;102:3314–3316.
   PubMed Web of Science ®Google Scholar
• Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001;98:6800–6805.
   PubMed Web of Science ®Google Scholar
• Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, . Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 2001;98:7498–7503.
   PubMed Web of Science ®Google Scholar
• Enioutina EY, Bareyan D, Daynes RA. TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J Immunol 2009;182:4296–4305.
   Google Scholar
• Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983;57:1308–1310.
   PubMed Web of Science ®Google Scholar
• Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983;221:1181–1183.
   PubMed Web of Science ®Google Scholar
• Nunn JD, Katz DR, Barker S, Fraher LJ, Hewison M, Hendy GN, . Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3. Immunology 1986;59:479–484.
   PubMedGoogle Scholar
• Provvedini DM, Manolagas SC. 1 Alpha,25-dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J Clin Endocrinol Metab 1989;68: 774–779.
   PubMed Web of Science ®Google Scholar
• Karmali R, Hewison M, Rayment N, Farrow SM, Brennan A, Katz DR, . 1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes. Immunology 1991;74: 589–593.
   PubMedGoogle Scholar
• Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995;125: 1704S–1708S.
   PubMed Web of Science ®Google Scholar
• Overbergh L, Decallonne B, Waer M, Rutgeerts O, Valckx D, Casteels KM, . 1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524 - 543). Diabetes 2000;49:1301–1307.
   PubMed Web of Science ®Google Scholar
• Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha,25-Dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001;167:4974–4980.
   PubMed Web of Science ®Google Scholar
• Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006;18:349–356.
   PubMed Web of Science ®Google Scholar
• Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821–852.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007;19: 652–657.
   PubMed Web of Science ®Google Scholar
• Korn T, Oukka M, Kuchroo V, Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin Immunol 2007;19:362–371.
   PubMed Web of Science ®Google Scholar
• Chang SH, Chung Y, Dong C. Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J Biol Chem 2010;285: 38751–38755.
   PubMed Web of Science ®Google Scholar
• Colin EM, Asmawidjaja PS, van Hamburg JP, Mus AM, van Driel M, Hazes JM, van Leeuwen JP, Lubberts E. 1, 25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 2010;62: 132–142.
   PubMed Web of Science ®Google Scholar
• Palmer MT, Lee YK, Maynard CL, Oliver JR, Bikle DD, Jetten AM, . Lineage-specific effects of 1, 25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem 2010;286:997–1004.
   Google Scholar
• Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008;324:23–33.
   PubMed Web of Science ®Google Scholar
• Liu N, Nguyen L, Chun RF, Lagishetty V, Ren S, Wu S, . Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology 2008;149:4799–4808.
   PubMedGoogle Scholar
• Gorman S, Kuritzky LA, Judge MA, Dixon KM, McGlade JP, Mason RS, . Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4 + CD25 + cells in the draining lymph nodes. J Immunol 2007;179: 6273–6283.
   PubMed Web of Science ®Google Scholar
• Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 2002;51:1367–1374.
   PubMed Web of Science ®Google Scholar
• Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mellitus: state of the art. Trends Endocrinol Metab 2005;16:261–266.
   PubMed Web of Science ®Google Scholar
• Spach KM, Nashold FE, Dittel BN, Hayes CE. IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J Immunol 2006;177:6030–6037.
   PubMed Web of Science ®Google Scholar
• Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, . 1,25-Dihydroxyvitamin D(3) and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009;183: 5458–5467.
   PubMed Web of Science ®Google Scholar
• Urry Z, Xystrakis E, Richards DF, McDonald J, Sattar Z, Cousins DJ, . Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest 2009;119:387–398.
   PubMed Web of Science ®Google Scholar
• Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001;167:1945–1953.
   PubMed Web of Science ®Google Scholar
• Dong X, Bachman LA, Kumar R, Griffin MD. Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning. Transpl Immunol 2003;11:323–333.
   PubMed Web of Science ®Google Scholar
• Adorini L, Penna G, Giarratana N, Roncari A, Amuchastegui S, Daniel KC, . Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol 2004;89–90:437–441.
   Google Scholar
• Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000;374:334–338.
   PubMed Web of Science ®Google Scholar
• Iho S, Iwamoto K, Kura F, Okuno Y, Takahashi T, Hoshino T. Mechanism in 1,25(OH)2D3-induced suppression of helper/suppressor function of CD4/CD8 cells to immunoglobulin production in B cells. Cell Immunol 1990;127:12–25.
   PubMed Web of Science ®Google Scholar
• Yu S, Bruce D, Froicu M, Weaver V, Cantorna MT. Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice. Proc Natl Acad Sci USA 2008;105:20834–20839.
   PubMed Web of Science ®Google Scholar
• Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, . DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007;8:285–293.
   PubMed Web of Science ®Google Scholar
• Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1, 25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol 2004;34:1068–1076.
   PubMed Web of Science ®Google Scholar
• Meehan TF, DeLuca HF. CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A 2002;99:5557–5560.
   Google Scholar
• Cantorna MT, Hayes CE, DeLuca HF. 1, 25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 1996;93:7861–7864.
   PubMed Web of Science ®Google Scholar
• Shiozawa K, Shiozawa S, Shimizu S, Fujita T. 1 alpha, 25-dihydroxyvitamin D3 inhibits pokeweed mitogen-stimulated human B-cell activation: an analysis using serum-free culture conditions. Immunology 1985;56:161–167.
   PubMed Web of Science ®Google Scholar
• Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1 alpha,25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J Immunol 1986;136:2734–2740.
   PubMed Web of Science ®Google Scholar
• Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179:1634–1647.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Nakayama Y, Horiuchi H, Ohta T, Komoriya K, Ohmori H, . Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha, 25-dihydroxyvitamin D3. Immunopharmacol Immunotoxicol 2002;24:335–347.
   PubMed Web of Science ®Google Scholar
• Sorensen O, Cowland JB, Askaa J, Borregaard N. An ELISA for hCAP-18, the cathelicidin present in human neutrophils and plasma. J Immunol Methods 1997;206:53–59.
   Google Scholar